Tags

Type your tag names separated by a space and hit enter

Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium.
J Neurosurg Pediatr. 2022 Apr 15 [Online ahead of print]JN

Abstract

OBJECTIVE

The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM).

METHODS

The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups.

RESULTS

A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD.

CONCLUSIONS

PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months.

Authors+Show Affiliations

1Division of Pediatric Neurosurgery, Penn State Health Children's Hospital, Hershey, PA.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.3Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN.4Division of Pediatric Neurosurgery, Barrow Neurological Institute at Phoenix Children's Hospital, Phoenix, AZ.5Department of Neurological Surgery, University of Wisconsin at Madison, Madison, WI.6Division of Neurosurgery, Arkansas Children's Hospital, Little Rock, AR.7Division of Pediatric Neurosurgery, University of Florida College of Medicine, Jacksonville, FL.8Division of Pediatric Neurosurgery, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL.9Division of Pediatric Neurosurgery, Department of Neurological Surgery, Children's Hospital of New York, Columbia-Presbyterian, New York, NY.10Division of Pediatric Neurosurgery, Texas Children's Hospital, Houston, TX.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.36Division of Pediatric Neurosurgery, Cincinnati Children's Medical Center, Cincinnati, OH.11Division of Pediatric Neurosurgery, Primary Children's Hospital, Salt Lake City, UT.12Division of Pediatric Neurosurgery, Children's Healthcare of Atlanta University, Atlanta, GA.13Department of Neurological Surgery, Wake Forest University School of Medicine, Winston-Salem, NC.14Department of Neurosurgery, Mayo Clinic, Rochester, MN.15Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA.16Division of Pediatric Neurosurgery, Children's Hospital of Los Angeles, Los Angeles, CA.17Division of Pediatric Neurosurgery, Seattle Children's Hospital, Seattle, WA.18Department of Neurosurgery, Medical University of South Carolina, Charleston, SC.19Department of Neurosurgery, Duke University School of Medicine, Durham, NC.20Division of Pediatric Neurosurgery, Lucile Packard Children's Hospital, Palo Alto, CA.21Division of Pediatric Neurosurgery, Gillette Children's Hospital, St. Paul, MN.22Division of Pediatric Neurosurgery, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, PA.23Department of Neurological Surgery, Weill Cornell Medical College, NewYork-Presbyterian Hospital, New York, NY.24Department of Neurosurgery, University of Oklahoma, Oklahoma City, OK.25Department of Neurosurgery, University of Minnesota Medical School, Minneapolis, MN.26Department of Neurosurgery, Children's Hospital Colorado, Aurora, CO.27Division of Pediatric Neurosurgery, Children's Hospital of Philadelphia, Philadelphia, PA.1Division of Pediatric Neurosurgery, Penn State Health Children's Hospital, Hershey, PA.5Department of Neurological Surgery, University of Wisconsin at Madison, Madison, WI.28Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, MD.29Division of Neurosurgery, Johns Hopkins All Children's Hospital, St. Petersburg, FL.30Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL.31Department of Neurosurgery, Medical College of Wisconsin, Milwaukee, WI.32Department of Neurosurgery, Children's National Medical Center, Washington, DC.33Department of Neurosurgery, The University of Tennessee Health Science Center, Memphis, TN.16Division of Pediatric Neurosurgery, Children's Hospital of Los Angeles, Los Angeles, CA.34Division of Pediatric Neurosurgery, Nationwide Children's Hospital, Columbus, OH.35Department of Neurosurgery, University of Michigan, Ann Arbor, MI.36Division of Pediatric Neurosurgery, Cincinnati Children's Medical Center, Cincinnati, OH.16Division of Pediatric Neurosurgery, Children's Hospital of Los Angeles, Los Angeles, CA.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.15Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA.33Department of Neurosurgery, The University of Tennessee Health Science Center, Memphis, TN.26Department of Neurosurgery, Children's Hospital Colorado, Aurora, CO.37Division of Pediatric Neurosurgery, Arnold Palmer Hospital for Children, Orlando, FL.38Department of Neurological Surgery, University of Miami School of Medicine, Miami, FL.39Department of Neurological Surgery and Doernbecher Children's Hospital, Oregon Health & Science University, Portland, OR.40Division of Pediatric Neurosurgery, McGovern Medical School, Houston, TX.41Division of Pediatric Neurosurgery, Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville, TN.42Department of Radiology, Washington University School of Medicine, St. Louis, MO.29Division of Neurosurgery, Johns Hopkins All Children's Hospital, St. Petersburg, FL.43Division of Pediatric Neurosurgery, Boston Children's Hospital, Boston, MA.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.44Division of Neurosurgery, The University of British Columbia, Vancouver, BC, Canada.15Department of Neurosurgery, University of Iowa Hospitals and Clinics, Iowa City, IA.29Division of Neurosurgery, Johns Hopkins All Children's Hospital, St. Petersburg, FL.45Department of Neurosurgery, The University of Texas at Austin, Austin, TX; and.46Carolina Neurosurgery & Spine Associates, Charlotte, NC.41Division of Pediatric Neurosurgery, Monroe Carell Jr. Children's Hospital at Vanderbilt University, Nashville, TN.10Division of Pediatric Neurosurgery, Texas Children's Hospital, Houston, TX.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.2Department of Neurological Surgery, Washington University School of Medicine, St. Louis, MO.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

35426814

Citation

Akbari, S Hassan A., et al. "Complications and Outcomes of Posterior Fossa Decompression With Duraplasty Versus Without Duraplasty for Pediatric Patients With Chiari Malformation Type I and Syringomyelia: a Study From the Park-Reeves Syringomyelia Research Consortium." Journal of Neurosurgery. Pediatrics, 2022, pp. 1-13.
Akbari SHA, Yahanda AT, Ackerman LL, et al. Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2022.
Akbari, S. H. A., Yahanda, A. T., Ackerman, L. L., Adelson, P. D., Ahmed, R., Albert, G. W., Aldana, P. R., Alden, T. D., Anderson, R. C. E., Bauer, D. F., Bethel-Anderson, T., Bierbrauer, K., Brockmeyer, D. L., Chern, J. J., Couture, D. E., Daniels, D. J., Dlouhy, B. J., Durham, S. R., Ellenbogen, R. G., ... Limbrick, D. D. (2022). Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. Journal of Neurosurgery. Pediatrics, 1-13. https://doi.org/10.3171/2022.2.PEDS21446
Akbari SHA, et al. Complications and Outcomes of Posterior Fossa Decompression With Duraplasty Versus Without Duraplasty for Pediatric Patients With Chiari Malformation Type I and Syringomyelia: a Study From the Park-Reeves Syringomyelia Research Consortium. J Neurosurg Pediatr. 2022 Apr 15;1-13. PubMed PMID: 35426814.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Complications and outcomes of posterior fossa decompression with duraplasty versus without duraplasty for pediatric patients with Chiari malformation type I and syringomyelia: a study from the Park-Reeves Syringomyelia Research Consortium. AU - Akbari,S Hassan A, AU - Yahanda,Alexander T, AU - Ackerman,Laurie L, AU - Adelson,P David, AU - Ahmed,Raheel, AU - Albert,Gregory W, AU - Aldana,Philipp R, AU - Alden,Tord D, AU - Anderson,Richard C E, AU - Bauer,David F, AU - Bethel-Anderson,Tammy, AU - Bierbrauer,Karin, AU - Brockmeyer,Douglas L, AU - Chern,Joshua J, AU - Couture,Daniel E, AU - Daniels,David J, AU - Dlouhy,Brian J, AU - Durham,Susan R, AU - Ellenbogen,Richard G, AU - Eskandari,Ramin, AU - Fuchs,Herbert E, AU - Grant,Gerald A, AU - Graupman,Patrick C, AU - Greene,Stephanie, AU - Greenfield,Jeffrey P, AU - Gross,Naina L, AU - Guillaume,Daniel J, AU - Hankinson,Todd C, AU - Heuer,Gregory G, AU - Iantosca,Mark, AU - Iskandar,Bermans J, AU - Jackson,Eric M, AU - Jallo,George I, AU - Johnston,James M, AU - Kaufman,Bruce A, AU - Keating,Robert F, AU - Khan,Nicklaus R, AU - Krieger,Mark D, AU - Leonard,Jeffrey R, AU - Maher,Cormac O, AU - Mangano,Francesco T, AU - McComb,J Gordon, AU - McEvoy,Sean D, AU - Meehan,Thanda, AU - Menezes,Arnold H, AU - Muhlbauer,Michael S, AU - O'Neill,Brent R, AU - Olavarria,Greg, AU - Ragheb,John, AU - Selden,Nathan R, AU - Shah,Manish N, AU - Shannon,Chevis N, AU - Shimony,Joshua S, AU - Smyth,Matthew D, AU - Stone,Scellig S D, AU - Strahle,Jennifer M, AU - Tamber,Mandeep S, AU - Torner,James C, AU - Tuite,Gerald F, AU - Tyler-Kabara,Elizabeth C, AU - Wait,Scott D, AU - Wellons,John C, AU - Whitehead,William E, AU - Park,Tae Sung, AU - Limbrick,David D, Y1 - 2022/04/15/ PY - 2021/09/07/received PY - 2022/02/28/accepted PY - 2022/4/15/entrez PY - 2022/4/16/pubmed PY - 2022/4/16/medline KW - Chiari malformation KW - Park-Reeves KW - duraplasty KW - posterior fossa decompression KW - syringomyelia SP - 1 EP - 13 JF - Journal of neurosurgery. Pediatrics JO - J Neurosurg Pediatr N2 - OBJECTIVE: The aim of this study was to determine differences in complications and outcomes between posterior fossa decompression with duraplasty (PFDD) and without duraplasty (PFD) for the treatment of pediatric Chiari malformation type I (CM1) and syringomyelia (SM). METHODS: The authors used retrospective and prospective components of the Park-Reeves Syringomyelia Research Consortium database to identify pediatric patients with CM1-SM who received PFD or PFDD and had at least 1 year of follow-up data. Preoperative, treatment, and postoperative characteristics were recorded and compared between groups. RESULTS: A total of 692 patients met the inclusion criteria for this database study. PFD was performed in 117 (16.9%) and PFDD in 575 (83.1%) patients. The mean age at surgery was 9.86 years, and the mean follow-up time was 2.73 years. There were no significant differences in presenting signs or symptoms between groups, although the preoperative syrinx size was smaller in the PFD group. The PFD group had a shorter mean operating room time (p < 0.0001), fewer patients with > 50 mL of blood loss (p = 0.04), and shorter hospital stays (p = 0.0001). There were 4 intraoperative complications, all within the PFDD group (0.7%, p > 0.99). Patients undergoing PFDD had a 6-month complication rate of 24.3%, compared with 13.7% in the PFD group (p = 0.01). There were no differences between groups for postoperative complications beyond 6 months (p = 0.33). PFD patients were more likely to require revision surgery (17.9% vs 8.3%, p = 0.002). PFDD was associated with greater improvements in headaches (89.6% vs 80.8%, p = 0.04) and back pain (86.5% vs 59.1%, p = 0.01). There were no differences between groups for improvement in neurological examination findings. PFDD was associated with greater reduction in anteroposterior syrinx size (43.7% vs 26.9%, p = 0.0001) and syrinx length (18.9% vs 5.6%, p = 0.04) compared with PFD. CONCLUSIONS: PFD was associated with reduced operative time and blood loss, shorter hospital stays, and fewer postoperative complications within 6 months. However, PFDD was associated with better symptom improvement and reduction in syrinx size and lower rates of revision decompression. The two surgeries have low intraoperative complication rates and comparable complication rates beyond 6 months. SN - 1933-0715 UR - https://www.unboundmedicine.com/medline/citation/35426814/Complications_and_outcomes_of_posterior_fossa_decompression_with_duraplasty_versus_without_duraplasty_for_pediatric_patients_with_Chiari_malformation_type_I_and_syringomyelia:_a_study_from_the_Park_Reeves_Syringomyelia_Research_Consortium_ DB - PRIME DP - Unbound Medicine ER -